Diabetic Foot Files

From seizures to Granulation Nation: The Unexpected Story of Phenytoin in Wound Healing

24 min · 13 de jun de 2026
Portada del episodio From seizures to Granulation Nation: The Unexpected Story of Phenytoin in Wound Healing

Descripción

This episode traces how phenytoin — an anticonvulsant known for causing gingival overgrowth — was repurposed into a topical therapy for chronic wounds. It outlines the drug’s mechanisms in wounds: activating fibroblasts, increasing collagen synthesis, reducing MMP activity, modulating inflammation, and promoting granulation and angiogenesis in stalled diabetic foot ulcers. Listeners will hear clinical implications, common formulations, and important cautions: topical phenytoin can aid healing in selected chronic ulcers but does not replace debridement, offloading, vascular optimization, or infection control, and should be avoided in malignant wounds, untreated osteomyelitis, or critical ischemia. The episode also highlights the drug’s history and future delivery innovations.

Comentarios

0

Sé la primera persona en comentar

¡Regístrate ahora y únete a la comunidad de Diabetic Foot Files!

Empezar

2 meses por 1 €

Después 4,99 € / mes · Cancela cuando quieras.

  • Podcasts exclusivos
  • 20 horas de audiolibros / mes
  • Podcast gratuitos

Todos los episodios

319 episodios

Portada del episodio From seizures to Granulation Nation: The Unexpected Story of Phenytoin in Wound Healing

From seizures to Granulation Nation: The Unexpected Story of Phenytoin in Wound Healing

This episode traces how phenytoin — an anticonvulsant known for causing gingival overgrowth — was repurposed into a topical therapy for chronic wounds. It outlines the drug’s mechanisms in wounds: activating fibroblasts, increasing collagen synthesis, reducing MMP activity, modulating inflammation, and promoting granulation and angiogenesis in stalled diabetic foot ulcers. Listeners will hear clinical implications, common formulations, and important cautions: topical phenytoin can aid healing in selected chronic ulcers but does not replace debridement, offloading, vascular optimization, or infection control, and should be avoided in malignant wounds, untreated osteomyelitis, or critical ischemia. The episode also highlights the drug’s history and future delivery innovations.

13 de jun de 202624 min